Results 131 to 140 of about 2,377,916 (241)

Catheter Ablation Versus Medical Therapy in Atrial Fibrillation With Heart Failure With Reduced or Mildly Reduced Ejection Fraction: A GRADE‐Assessed Systematic Review and Meta‐Analysis

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
In patients with atrial fibrillation and HFmrEF/HFrEF, catheter ablation was associated with lower mortality and improved cardiac function compared with conventional medical therapy, while cardiovascular hospitalization was not significantly reduced. The overall certainty of evidence ranged from moderate to high.
Aleena Amir Malik, Nasir Saeed, Goodluck Oparaugo, Muhammad Waqar Shahid, Waqas Kareem, Fatima Yousaf, Zain Ul Abedeen, Fatima Sajjad, Kashif Yousaf, Fizza Kazmi, Rubab Zahra, Ishfaq Ali, Sahil Kumar, Tanzeela Gul, Zartasha Rahim, Abdul Basit, Manal Sharif, Anum Noor, Habib ur Rehman, Imdad Ullah Shah, Abdullah Afridi   +20 more
wiley   +1 more source

High‐Density Spectral Analysis for Bi‐Atrial Arrhythmogenic Substrate During Non‐Paroxysmal Atrial Fibrillation

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
Analyzing 48 153 CARTOFINDER mapping points revealed that both FoA and RoA sites demonstrated elevated DF deviation (DFD) and RI compared to non‐sites. While both metrics increased progressively with FoA repetitions, high‐repetition RoA sites paradoxically displayed lower values.
Nobunari Tomura, Keitaro Senoo, Taku Ohkawa, Yusuke Kakei, Kohei Kawai, Masahiro Makino, Jun Munakata, Tomonori Miki, Yukinori Kato, Kento Fukui, Hiroki Kitajima, Suguru Nishiuchi, Ken Kakita, Daisuke Sato, Hirokazu Shiraishi, Satoaki Matoba   +15 more
wiley   +1 more source

Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation. [PDF]

Eur Heart J Suppl, 2020
Stazi F.
europepmc   +1 more source

5G Cloud‐Enabled Telemedicine for Remote Management of Heart Failure Patients With Implantable Cardioverter‐Defibrillators: A Multicenter Open‐Label Randomized Controlled Trial

MedComm, Volume 7, Issue 10, October 2026.
Postoperative follow‐up for patients with implantable cardioverter‐defibrillators and cardiac resynchronization therapy defibrillators (ICD/CRT‐D) is often delayed in remote areas because of geographic barriers and limited healthcare resources, increasing the risk of adverse outcomes. The “Make Changes” study, was a prospective, multicenter, open‐label
Pan Li, Fayuan Fu, Yiding Qi, Xianxian Zhao, Yingyi Qin, Xinghua Shan, Jing Jiang, Guowei Wang, Jingjuan Huang, Bo Liu, Zhifu Guo, Zhongkai Wang   +11 more
wiley   +1 more source

Rare Case of Fetal Permanent Junctional Reciprocating Tachycardia Refractory to Prenatal Antiarrhythmic Therapy. [PDF]

Mayo Clin Proc Innov Qual Outcomes, 2020
Narang K, Rose CH, Johnson JN, Wackel PL, Cetta F.   +4 more
europepmc   +1 more source

Epicardial adipose tissue‐linked leukotriene and cytokine signalling pathways – novel targets for prevention of obesity‐ and diabetes‐linked ventricular arrhythmia

The Journal of Physiology, EarlyView.
Kelly A. Aromolaran, Ademuyiwa S. Aromolaran   +1 more
wiley   +1 more source

Rosemary metabolite carnosic acid opens Kv1.1 via its voltage sensor and corrects Kv1.1‐linked episodic ataxia in mice

British Journal of Pharmacology, Volume 183, Issue 20, Page 6179-6198, October 2026.
Background and Purpose Episodic ataxia type 1 (EA1) is an autosomal dominant neurological disorder caused primarily by loss‐of‐function mutations in the voltage‐gated potassium channel Kv1.1 (KCNA1). Small molecules that restore Kv1.1 activity hold promise as targeted therapies for EA1, yet current pharmacological strategies remain limited ...
Rían W. Manville, Ryan F. Yoshimura, Hanh A. Nguyen, Ruiming Zhao, Derk J. Hogenkamp, Steve A. N. Goldstein, Geoffrey W. Abbott   +6 more
wiley   +1 more source

Response to equine cardiac adverse events during sports

Equine Veterinary Education, Volume 38, Issue 10, Page 556-564, October 2026.
Summary Cardiac adverse events and sudden death are a feared scenario for equine veterinarians, with serious consequences for animal health, riders' safety and the social licence to operate equestrian sports. The response to equine cardiac adverse events (CAEs) during sports is poorly defined.
C. Navas de Solis, J. Keen, A. Decloedt, B. Delvescovo, K. Hopster, K. Mitchell, J. Slack, G. van Loon, G. Van Steenkiste, L. Nath   +9 more
wiley   +1 more source

Comparative Effectiveness of Amiodarone Versus Lidocaine as Antiarrhythmic Therapy for Cardiac Arrest with Shockable Rhythms: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Ahmed F, Zulfiqar A, Nihal T, Khalid M, Islam MR, Abubakar F, Saleem NUA, Tahir HB, Raja HAA, Dar A, Kamel O, Haider F, Rauf S, Ayub W, Dadhania K, Haider MZ, Sattar Y, Taha A.   +17 more
europepmc   +1 more source

Management of recurrent atrial fibrillation after catheter ablation: 5-year outcomes of repeat catheter ablation vs. antiarrhythmic therapy. [PDF]

Europace
Yeo YH, Wong HKK, Vignarajah A, Tan MC, Vigneswaramoorthy N, Lee J, Scott L, Tamirisa KP, Sorajja D, DeSimone C.   +9 more
europepmc   +1 more source